[go: up one dir, main page]

NL192250B - Osmotic device for the controlled rate of delivery of a beneficial agent. - Google Patents

Osmotic device for the controlled rate of delivery of a beneficial agent.

Info

Publication number
NL192250B
NL192250B NL8401470A NL8401470A NL192250B NL 192250 B NL192250 B NL 192250B NL 8401470 A NL8401470 A NL 8401470A NL 8401470 A NL8401470 A NL 8401470A NL 192250 B NL192250 B NL 192250B
Authority
NL
Netherlands
Prior art keywords
delivery
beneficial agent
controlled rate
osmotic device
osmotic
Prior art date
Application number
NL8401470A
Other languages
Dutch (nl)
Other versions
NL8401470A (en
NL192250C (en
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23961585&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL192250(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Publication of NL8401470A publication Critical patent/NL8401470A/en
Publication of NL192250B publication Critical patent/NL192250B/en
Application granted granted Critical
Publication of NL192250C publication Critical patent/NL192250C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
NL8401470A 1983-05-11 1984-05-08 Osmotic device for the controlled rate of delivery of a beneficial agent. NL192250C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49376083A 1983-05-11 1983-05-11
US49376083 1983-05-11

Publications (3)

Publication Number Publication Date
NL8401470A NL8401470A (en) 1984-12-03
NL192250B true NL192250B (en) 1996-12-02
NL192250C NL192250C (en) 1997-04-03

Family

ID=23961585

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8401470A NL192250C (en) 1983-05-11 1984-05-08 Osmotic device for the controlled rate of delivery of a beneficial agent.

Country Status (20)

Country Link
JP (1) JPS6041609A (en)
AT (1) AT397180B (en)
AU (1) AU566110B2 (en)
BE (1) BE898819A (en)
CA (1) CA1222950A (en)
CH (1) CH669329A5 (en)
DE (1) DE3417113A1 (en)
DK (1) DK163910C (en)
ES (1) ES532018A0 (en)
FR (1) FR2545721B1 (en)
GB (1) GB2140687B (en)
IE (1) IE56515B1 (en)
IL (1) IL71727A (en)
IT (1) IT1178911B (en)
MX (1) MX163518B (en)
NL (1) NL192250C (en)
NO (1) NO170834C (en)
NZ (1) NZ206600A (en)
SE (1) SE455918B (en)
ZA (1) ZA842422B (en)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075457B2 (en) * 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド Pharmaceutical composition allowing the release of the active ingredient in a controlled manner
US4600773A (en) * 1983-12-01 1986-07-15 Eli Lilly And Company Crystalline cephalexin hydrochloride monohydrate
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
ES8800043A1 (en) * 1985-08-16 1987-10-16 Alza Corp Osmotic dispenser
US4963141A (en) * 1985-08-16 1990-10-16 Alza Corporation Dispensing system for administering beneficial agent formulation to ruminants
US4704118A (en) * 1985-08-16 1987-11-03 Alza Corporation Ruminant dispensing device with thermo-activated memory
US4723957A (en) * 1986-02-07 1988-02-09 Alza Corp. System for delivering drug with enhanced bioacceptability
US4716496A (en) * 1986-05-09 1987-12-29 Eaton Corporation Panel-mounted control station housing
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
EP0317780B1 (en) * 1987-11-25 1992-05-20 American Cyanamid Company Sustained (controlled) release delivery system for substituted dihydropyridine calcium channel blockers
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
GR1000270B (en) * 1988-09-30 1992-05-12 Alza Corp Dose for cardiovascular troubles therapy
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US5000962A (en) * 1989-08-25 1991-03-19 Schering Corporation Long acting diltiazem formulation
US4992277A (en) * 1989-08-25 1991-02-12 Schering Corporation Immediate release diltiazem formulation
US5067960A (en) * 1989-12-06 1991-11-26 Medtronic, Inc. Muscle fitness detection by colorimetry
US5190763A (en) * 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5081161A (en) * 1990-06-15 1992-01-14 E. I. Du Pont De Nemours And Company Process for making shaped articles of a thermoplastic resin having a microcellular structure
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
WO1992002212A2 (en) * 1990-08-07 1992-02-20 Pfizer Inc. Use of interfacially-polymerized membranes in delivery devices
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy
US5431921A (en) * 1990-09-28 1995-07-11 Pfizer Inc Dispensing device containing a hydrophobic medium
US5208037A (en) * 1991-04-22 1993-05-04 Alza Corporation Dosage forms comprising polymers comprising different molecular weights
EP0612519B1 (en) * 1993-02-23 2001-04-04 Wolfgang Dr. Werner Use of a calcium formulation in a medicament for therapeutic application to milk cows suffering from hypocalcaemia
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6287598B1 (en) * 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
US5460826A (en) * 1994-06-27 1995-10-24 Alza Corporation Morphine therapy
US5948787A (en) * 1997-02-28 1999-09-07 Alza Corporation Compositions containing opiate analgesics
DE19962924A1 (en) 1999-12-24 2001-07-05 Bayer Ag Substituted oxazolidinones and their use
EP2263658A1 (en) * 2000-10-30 2010-12-22 Euro-Celtique S.A. Controlled release hydrocodone formulations
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
DE10129725A1 (en) 2001-06-20 2003-01-02 Bayer Ag Combination therapy of substituted oxazolidinones
DE10300111A1 (en) 2003-01-07 2004-07-15 Bayer Healthcare Ag Process for the preparation of 5-chloro-N - ({(5S) -2-oxo-3- [4- (3-oxo-4-morpholinyl) phenyl] -1,3-oxazolidin-5-yl} methyl ) -2-thiophenecarboxamide
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
EA013106B1 (en) 2003-09-19 2010-02-26 Сан Фарма Адвансед Ресьорч Компани Лтд. Oral drug delivery system
DE10355461A1 (en) 2003-11-27 2005-06-23 Bayer Healthcare Ag Solid, high bioavailabilty oral formulations of N-substituted 5-chloro-2-thiophene-carboxamide derivative in hydrophilized form, useful for combating thrombo-embolic diseases
DE102004062475A1 (en) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Solid, orally administrable, modified release pharmaceutical dosage forms
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005031577A1 (en) * 2005-07-06 2007-01-11 Bayer Healthcare Ag Pharmaceutical dosage forms containing a combination of nifedipine and / or nisoldipine and an angiotensin II antagonist
DE102005045518A1 (en) 2005-09-23 2007-03-29 Bayer Healthcare Ag New 5-thienylaminocarbonylmethyl-oxazolidin-2-one derivatives, useful for treating and preventing thromboembolic disease, are selective inhibitors of coagulation factor Xa
RU2578602C2 (en) 2005-10-04 2016-03-27 Байер Интеллектуэль Проперти Гмбх Method for obtaining 5-chloro-n-(5s)-2-oxo-3-[4-(3-oxo-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide in modification ii (versions)
DE102005047561A1 (en) 2005-10-04 2007-04-05 Bayer Healthcare Ag Drug delivery system, useful to treat and/or prevent e.g. thromboembolic disease, comprises 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxo-4-morpholinyl)-phenyl)-1,3-oxazolidine-5-yl)-methyl)-2-thiophene carboxamide with fast release active substance
DE102008059206A1 (en) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical dosage form containing nifedipine or nisoldipine and an angiotensin II antagonist and / or a diuretic
KR20140069381A (en) * 2009-06-02 2014-06-10 다우 글로벌 테크놀로지스 엘엘씨 Sustained release dosage form
DE102011007272A1 (en) 2011-04-13 2012-10-18 Bayer Pharma Aktiengesellschaft Branched 3-phenylpropionic acid derivatives and their use
CA2872542A1 (en) 2012-05-07 2013-11-14 Bayer Pharma Aktiengesellschaft Process for manufacturing a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil
UY34856A (en) 2012-07-03 2013-12-31 Bayer Pharma AG PHARMACEUTICAL PRESENTATION FORMS CONTAINING 5-CHLORO-N - ({(5S) -2-OXO-3- [4- (3-OXO-4- MORPHOLINYL) -PHENYL] -1,3-OXAZOLIDIN-5-IL} -METIL) -2-THIOFENCARBOXAMIDE
JP5941117B2 (en) * 2014-10-17 2016-06-29 ダウ グローバル テクノロジーズ エルエルシー Sustained release formulation
US10905667B2 (en) 2018-07-24 2021-02-02 Bayer Pharma Aktiengesellschaft Orally administrable modified-release pharmaceutical dosage form
KR20210035235A (en) 2018-07-24 2021-03-31 바이엘 악티엔게젤샤프트 Pharmaceutical dosage forms that can be administered orally and have modified release
EP3826619A1 (en) 2018-07-24 2021-06-02 Bayer Aktiengesellschaft Pharmaceutical dosage form which can be administered orally and has modified release

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL38538A (en) * 1971-01-13 1974-09-10 Alza Corp Osmotic dispenser
US3977404A (en) * 1975-09-08 1976-08-31 Alza Corporation Osmotic device having microporous reservoir
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device

Also Published As

Publication number Publication date
DE3417113C2 (en) 1989-02-02
ATA88084A (en) 1993-07-15
DE3417113A1 (en) 1984-11-15
CA1222950A (en) 1987-06-16
ES8503503A1 (en) 1985-03-01
FR2545721A1 (en) 1984-11-16
FR2545721B1 (en) 1987-11-06
NL8401470A (en) 1984-12-03
AU2251183A (en) 1984-11-15
AT397180B (en) 1994-02-25
AU566110B2 (en) 1987-10-08
CH669329A5 (en) 1989-03-15
DK99784A (en) 1984-11-12
BE898819A (en) 1984-05-30
DK163910C (en) 1992-09-14
IE56515B1 (en) 1991-08-28
IL71727A0 (en) 1984-09-30
IT8467283A1 (en) 1985-09-23
IL71727A (en) 1989-01-31
ES532018A0 (en) 1985-03-01
IE840010L (en) 1984-11-11
GB8334189D0 (en) 1984-02-01
DK99784D0 (en) 1984-02-24
GB2140687A (en) 1984-12-05
IT1178911B (en) 1987-09-16
NZ206600A (en) 1987-01-23
IT8467283A0 (en) 1984-03-23
JPS6041609A (en) 1985-03-05
SE455918B (en) 1988-08-22
ZA842422B (en) 1984-11-28
NL192250C (en) 1997-04-03
SE8402512D0 (en) 1984-05-09
NO170834B (en) 1992-09-07
SE8402512L (en) 1984-11-12
MX163518B (en) 1992-05-25
DK163910B (en) 1992-04-21
NO840248L (en) 1984-11-12
GB2140687B (en) 1987-03-18
NO170834C (en) 1992-12-16
JPH0575725B2 (en) 1993-10-21

Similar Documents

Publication Publication Date Title
NL192250B (en) Osmotic device for the controlled rate of delivery of a beneficial agent.
NL192720B (en) Osmotic device for delivering an agent advantageous for an environment of use.
NL188018C (en) DISPENSING HEAD FOR LIQUID.
NL192115B (en) Process for the preparation of a propelling agent and manufactured propopping agent.
NL8400785A (en) SULPHONIUM COMPOUNDS, METHODS FOR PREPARING THE COMPOUNDS AND PHARMACOLOGICAL COMPOSITIONS CONTAINING THESE COMPOUNDS.
NL193164B (en) Pharmaceutical tablet for controlled, sustained release of an active compound.
NL172723C (en) DEVICE FOR MAKING A CUT IN THE ARRANGEMENT OF A BIRD.
NL7700678A (en) PROCEDURE FOR FILLING THE TEETH AND PROCEDURE FOR PREPARING A SUITABLE PRODUCT.
NL183520C (en) PROCESS FOR THE PREPARATION OF A POLYURETHANE AND FOAM ARTICLES MANUFACTURED USING THE POLYURETHANE PREPARED SO
EP0058205A4 (en) Ultrasonic warning system.
NL190814C (en) Process for preparing a polyacetal copolymer.
NL7611104A (en) SYSTEM FOR INCREASING THE PULSE RATE OF A LASER.
NL183984C (en) DEVICE FOR ADJUSTING THE FLOW OF A LIQUID.
NL194715B (en) Preparation for the release of a composition of a beneficial agent.
IT8283433A0 (en) SPRAYER FOR ELASTIC CONTAINER.
NL187084C (en) DEVICE FOR TRANSMITTING A ROTATING MOVEMENT.
NL7706981A (en) DEVICE FOR PENING A FRAME FOR A PAINTING OR THE LIKE.
NL186368B (en) LIQUID PREPARATION FOR MANUFACTURING A MEMBRANE AND METHOD FOR MANUFACTURING A MEMBRANE.
NL189425B (en) METHOD FOR MANUFACTURING A SPIRAL-WRAPPED GASKET
NL186165C (en) PROCESS FOR PREPARING A POLYMERIC FLOCKING AGENT
NL188054C (en) INJECTOR AIR TREATMENT DEVICE FOR A ROOM.
JPS57186594A (en) Device for releasing lefeboat, etc.
NL178137C (en) DEVICE FOR CLEANING A TANK.
NL190759C (en) Glycoprotein, therapeutic agent for the treatment of leukopenia and method of preparing a glycoprotein.
NL7706152A (en) DEVICE FOR THE DELIVERY OF DEPOSIT FOR A FILLING EQUIPMENT.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20040508